# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties (NYSE:DOC) with a Sector Outperform and raises the price ...
JP Morgan analyst Michael Mueller maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from...
Healthpeak Properties, Inc. (NYSE:DOC) ("Healthpeak") and King Street Properties ("KSP") today announced that H...
Wedbush analyst Richard Anderson upgrades Healthpeak Properties (NYSE:DOC) from Neutral to Outperform.
Healthpeak Properties (NYSE:DOC) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0...
Mizuho analyst Omotayo Okusanya reinstates Healthpeak Properties (NYSE:DOC) with a Buy and announces $22 price target.